{"id":920,"date":"2010-10-29T05:21:26","date_gmt":"2010-10-28T23:51:26","guid":{"rendered":"http:\/\/www.apnaplan.com\/?p=920"},"modified":"2014-06-22T12:54:37","modified_gmt":"2014-06-22T07:24:37","slug":"ankur-drugs-and-pharma-ltd-fixed-deposit-scheme","status":"publish","type":"post","link":"https:\/\/www.apnaplan.com\/ankur-drugs-and-pharma-ltd-fixed-deposit-scheme\/","title":{"rendered":"Ankur Drugs and Pharma Ltd Fixed Deposit Scheme"},"content":{"rendered":"

\"Ankur_drugs_pharma_fixed_deposit_scheme\"<\/a>Company Profile:\u00a0Ankur Drugs and Pharma Ltd<\/strong><\/p>\n

A public limited company listed at Bombay Stock Exchange and National Stock Exchange of India Limited achieved a turnover of INR10691.90 Million for year ended March 31, 2010. Ankur is extensively engaged in the manufacturing of pharmaceutical formulation since 1997, having multi location manufacturing units located at Daman [Union Territory] and Baddi [Himachal Pradesh]. The Company’s major expansion program with a view to cater to the international market has been validated for commissioning.<\/p>\n

Our more than 400 different formulations of various dosage forms i.e. Tablets, Capsules, Dry Syrups, Liquid Orals, Injectables, Oinments, etc. are currently manufactured in Ankur’s multi location manufacturing facilities. Company has already received WHO GMP Certification for both Units at Himachal Pradesh.<\/p>\n

Interest Rate:\u00a0Ankur Drugs and Pharma Ltd Fixed Deposit Scheme<\/strong><\/p>\n\n\n\n\n\n\n\n
Scheme A:Quarterly Income Plan (Non-Cumulative)<\/strong><\/td>\n<\/tr>\n
Period (Year)<\/strong><\/td>\n\u00a0\u00a0Minimum Amount (Rs.)<\/strong><\/td>\n\u00a0\u00a0Rate of Interest (p.a.)<\/strong><\/td>\n<\/tr>\n
1<\/td>\n\u00a0\u00a025,000<\/td>\n\u00a0\u00a010.00 %<\/td>\n<\/tr>\n
2<\/td>\n\u00a0\u00a025,000<\/td>\n\u00a0\u00a011.00 %<\/td>\n<\/tr>\n
3<\/td>\n\u00a0\u00a025,000<\/td>\n\u00a0\u00a012.00 %<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n
Scheme B: Cumulative Deposit Plan (Interest compounded Quarterly)<\/strong><\/td>\n<\/tr>\n
Period (Year)<\/strong><\/td>\n\u00a0\u00a0Minimum Amount (Rs.)<\/strong><\/td>\n\u00a0\u00a0Rate of Interest (p.a.)<\/strong><\/td>\n\u00a0\u00a0Maturity Value (Rs.)<\/strong><\/td>\n\u00a0\u00a0Yield (p.a)<\/strong><\/td>\n<\/tr>\n
1<\/td>\n\u00a0\u00a025,000<\/td>\n\u00a0\u00a010.00 %<\/td>\n\u00a0\u00a027,595<\/td>\n\u00a0\u00a010.38 %<\/td>\n<\/tr>\n
2<\/td>\n\u00a0\u00a025,000<\/td>\n\u00a0\u00a011.00 %<\/td>\n\u00a0\u00a031,060<\/td>\n\u00a0\u00a012.12 %<\/td>\n<\/tr>\n
3<\/td>\n\u00a0\u00a025,000<\/td>\n\u00a0\u00a012.00 %<\/td>\n\u00a0\u00a035,644<\/td>\n\u00a0\u00a014.19 %<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

0.25 % p.a. additional interest for senior citizens \/ Shareholders (subject to a minimum of 200 shares) \/ Employees of\u00a0Ankur Drugs and Pharma Ltd. and its Indian Subsidiaries, if any.<\/p>\n

Features of\u00a0Ankur Drugs and Pharma Ltd Fixed Deposit Scheme:<\/strong><\/p>\n